Literature DB >> 16357536

CUTL1: a key mediator of TGFbeta-induced tumor invasion.

Patrick Michl1, Julian Downward.   

Abstract

The TGFbeta pathway plays a dual role in human carcinogenesis. On one hand, TGFbeta is well known for its ability to inhibit epithelial cell proliferation and promote apoptosis. However, many advanced cancers acquire resistance to the growth-inhibitory effects of TGFbeta and respond to it instead with promotion of proliferation, invasion and tumor progression. The homeobox transcription factor CUTL1, also known as CCAAT displacement protein, CDP or Cux-1, is involved in the control of normal embryonic development and differentiation. Recently, we found that CUTL1 is a transcriptional target of TGFbeta and is an important mediator of the TGFbeta-induced cell migration and invasion. In addition, CUTL1 is highly expressed in various epithelial cancers and seems to negatively correlate with tumor differentiation and patient survival. Therefore we postulate that CUTL1 might be a key mediator of the tumor-promoting effects of TGFbeta in advanced cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357536     DOI: 10.4161/cc.5.2.2311

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Authors:  Stefanie Ripka; Jan Riedel; Albrecht Neesse; Heidi Griesmann; Malte Buchholz; Volker Ellenrieder; Franz Moeller; Peter Barth; Thomas M Gress; Patrick Michl
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

2.  Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.

Authors:  Julia Starkova; Sharvari Gadgil; Yi Hua Qiu; Nianxiang Zhang; Ivana Hermanova; Steven M Kornblau; Harry A Drabkin
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

3.  TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells.

Authors:  S B Pakala; K Singh; S D N Reddy; K Ohshiro; D-Q Li; L Mishra; R Kumar
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

Review 4.  Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes.

Authors:  Ryan F Leung; Ankita M George; Enola M Roussel; Maree C Faux; Jeffrey T Wigle; David D Eisenstat
Journal:  Front Neurosci       Date:  2022-04-25       Impact factor: 5.152

Review 5.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

6.  Antagonistic regulation of apoptosis and differentiation by the Cut transcription factor represents a tumor-suppressing mechanism in Drosophila.

Authors:  Zongzhao Zhai; Nati Ha; Fani Papagiannouli; Anne Hamacher-Brady; Nathan Brady; Sebastian Sorge; Daniela Bezdan; Ingrid Lohmann
Journal:  PLoS Genet       Date:  2012-03-15       Impact factor: 5.917

7.  Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts.

Authors:  Tetsurou Ikeda; Maria Fragiadaki; Xu Shi-Wen; Markella Ponticos; Korsa Khan; Christopher Denton; Patricia Garcia; George Bou-Gharios; Akio Yamakawa; Chikao Morimoto; David Abraham
Journal:  Biochem Biophys Rep       Date:  2016-07-02

Review 8.  Regulation of cell proliferation and differentiation in the kidney.

Authors:  Neal I Alcalay; Gregory B Vanden Heuvel
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01

9.  Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array.

Authors:  Charles Vadnais; Arif A Awan; Ryoko Harada; Pier-Luc Clermont; Lam Leduy; Ginette Bérubé; Alain Nepveu
Journal:  BMC Genomics       Date:  2013-04-16       Impact factor: 3.969

10.  Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers.

Authors:  Charles Vadnais; Peiman Shooshtarizadeh; Charles V Rajadurai; Robert Lesurf; Laura Hulea; Sayeh Davoudi; Chantal Cadieux; Michael Hallett; Morag Park; Alain Nepveu
Journal:  Biol Open       Date:  2014-09-12       Impact factor: 2.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.